BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3190011)

  • 1. [Glucantime and allopurinol in the treatment of persistent infantile visceral leishmaniasis].
    de la Cruz Amorós E; Lambruschini Ferri N; Rodríguez Miguélez JM; Torres Simón JM
    An Esp Pediatr; 1988 Jul; 29(1):77-9. PubMed ID: 3190011
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucantime-resistant visceral leishmaniasis in immunocompromised patients.
    Verdejo J; Alvar J; Polo RM; González-Lahoz JM
    Am J Med; 1988 Jul; 85(1):128. PubMed ID: 3389377
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical follow-up examination after treatment of canine leishmaniasis.
    Moritz A; Steuber S; Greiner M
    Tokai J Exp Clin Med; 1998 Dec; 23(6):279-83. PubMed ID: 10622623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy.
    di Martino L; Mantovani MP; Gradoni L; Gramiccia M; Guandalini S
    Trans R Soc Trop Med Hyg; 1990; 84(4):534-5. PubMed ID: 2091347
    [No Abstract]   [Full Text] [Related]  

  • 5. Visceral leishmaniasis in a renal transplant recipient treated with allopurinol.
    Harzallah K; Belhadj R; Jemli B; Haloues M; Berraies N; Gargouri S; Hmida J; Battikh R; Manaa J
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):105-8. PubMed ID: 20061702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy of experimental visceral leishmaniasis in the opossum.
    White MR; Chapman WL; Hanson WL
    J Parasitol; 1989 Feb; 75(1):176-8. PubMed ID: 2918440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Visceral leishmaniasis with benign course in a patient infected with human immunodeficiency virus].
    Ribelles N; Casals A; Vallés J; Clotet B
    Med Clin (Barc); 1989 May; 92(17):679. PubMed ID: 2747338
    [No Abstract]   [Full Text] [Related]  

  • 8. [N-methyl glucamine antimoniate or Glucantime].
    Rapp C; Simon F; Dordain ML
    Med Trop (Mars); 2000; 60(4):342-3. PubMed ID: 11436584
    [No Abstract]   [Full Text] [Related]  

  • 9. Kala azar with disseminated dermal leishmaniasis.
    Kumar PV; Sadeghi E; Torabi S
    Am J Trop Med Hyg; 1989 Feb; 40(2):150-3. PubMed ID: 2919725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe leucopenia during treatment of visceral leishmaniasis.
    Hiçsönmez G; Jama H; Ozsoylu S
    Trans R Soc Trop Med Hyg; 1988; 82(3):417. PubMed ID: 3232176
    [No Abstract]   [Full Text] [Related]  

  • 11. PCR follow-up examination after treatment of canine leishmaniosis (CaL).
    Steuber S; Moritz A; Schirrmann I; Greiner M
    Tokai J Exp Clin Med; 1998 Dec; 23(6):285-92. PubMed ID: 10622624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kala-azar. Apropos of a case report in a Belgian woman].
    Coutellier P; Delgrange B
    Acta Clin Belg; 1989; 44(5):362-3. PubMed ID: 2609847
    [No Abstract]   [Full Text] [Related]  

  • 13. A case report of Kala-Azar in a kidney transplant patient.
    Malek Hosseini SA; Javid R; Salahi H; Nezakatgoo N; Ahmad E; Ghahramani N
    Transplant Proc; 1995 Oct; 27(5):2715. PubMed ID: 7482886
    [No Abstract]   [Full Text] [Related]  

  • 14. Fulminant hepatitis in an Italian infant with visceral leishmaniasis.
    di Martino L; Vajro P; Nocerino A; Scotti S; Napolitano G; Vegnente A
    Trans R Soc Trop Med Hyg; 1992; 86(1):34. PubMed ID: 1566298
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute pancreatitis during treatment with meglumine antimoniate (Glucantime)].
    Barthet M; Brunet P; Bernard JC; Dussol B; Rodor F; Jouglard J; Berland Y; Sahel J
    Gastroenterol Clin Biol; 1994; 18(1):90-2. PubMed ID: 8187998
    [No Abstract]   [Full Text] [Related]  

  • 16. The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol.
    Hueso M; Bover J; Serón D; Gil-Vernet S; Rufí G; Alsina J; Grinyó JM
    Nephrol Dial Transplant; 1999 Dec; 14(12):2941-3. PubMed ID: 10570102
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-epidemiological study of kala-azar in the south of Madrid].
    de la Serna FJ; Salto E; Valdés D; Vos Saus R
    Rev Sanid Hig Publica (Madr); 1987; 61(7-8):783-98. PubMed ID: 3438697
    [No Abstract]   [Full Text] [Related]  

  • 18. AIDS-associated leishmaniasis: an unusual gastro-duodenal presentation.
    Datry A; Similowski T; Jais P; Rosenheim M; Katlama C; Maheu E; Kazaz S; Fassin D; Danis M; Gentilini M
    Trans R Soc Trop Med Hyg; 1990; 84(2):239-40. PubMed ID: 2389314
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the effectiveness and toxicity of pentostam and glucantime in the treatment of cutaneous leishmaniasis].
    Sáenz RE; Paz HM; Johnson CM; Narvaez E; de Vásquez AM
    Rev Med Panama; 1987 Sep; 12(3):148-57. PubMed ID: 2827242
    [No Abstract]   [Full Text] [Related]  

  • 20. Allopurinol in the treatment of American cutaneous leishmaniasis.
    Herwaldt BL; Neva FA; Berman JD
    N Engl J Med; 1992 Aug; 327(7):498-9. PubMed ID: 1625745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.